Ethylene Oxide Sterilization (EO) of Medical Devices
Principles, Process and Regulatory Relevance for Non-EU Manufacturers
Sterilization is a critical pillar of medical device safety and regulatory compliance worldwide. Among the available sterilization technologies, ethylene oxide (EO) sterilization — also referred to as ETO or EtO sterilization — remains one of the most widely used methods, particularly for complex and temperature-sensitive medical devices.
For manufacturers based outside the European Union, EO sterilization is often a key enabling technology for accessing the EU market under the Medical Device Regulation (MDR) and for meeting internationally harmonised ISO standards.
Sterilization is a critical pillar of medical device safety and regulatory compliance worldwide. Among the available sterilization technologies, ethylene oxide (EO) sterilization — also referred to as ETO or EtO sterilization — remains one of the most widely used methods, particularly for complex and temperature-sensitive medical devices.
For manufacturers based outside the European Union, EO sterilization is often a key enabling technology for accessing the EU market under the Medical Device Regulation (MDR) and for meeting internationally harmonised ISO standards.
Does your medical device match the european standards?
We can help with your product. Book a free introductory call with qtec Healthcare Solutions and get in touch with our experts.
How Does Ethylene Oxide Sterilization Work?
Ethylene oxide sterilization is a chemical sterilization process that uses ethylene oxide gas to inactivate microorganisms such as:
- bacteria
- viruses
- fungi
- bacterial spores
The gas disrupts the DNA and reproductive capability of microorganisms, achieving effective sterilization at relatively low temperatures, making the process suitable for sensitive materials and complex device designs.
Which Medical Devices Are Sterilized Using Ethylene Oxide?
Ethylene oxide sterilization is particularly suitable for devices that cannot tolerate high temperatures, moisture or ionizing radiation.
Typical examples include:
- complex and pre-assembled medical instruments
- catheters and multi-lumen tubing
- devices containing electronics or sensors
- stents and wound dressings
- single-use kits and surgical sets
- products made from polymer resins and plastics
Due to its excellent penetration capability, EO gas can pass through permeable packaging materials and reach all exposed surfaces — even in multilayer or intricately packaged products.

Unsure whether EO sterilization is suitable for your device design?
Book a free introductory call with our sterilization experts and get your individual support.
Ethylene Oxide Sterilization Process – Step by Step
A typical EO sterilization cycle consists of three main phases:
1
Preconditioning
The products are conditioned at defined temperature and humidity levels. Proper preconditioning is essential to ensure reproducible sterilization performance and consistent microbial inactivation.
2
Sterilization
The products are placed in a sealed vacuum chamber and exposed to ethylene oxide gas for a defined period. Four key parameters determine sterilization effectiveness:
- EO gas concentration
- temperature
- relative humidity
- exposure time
3
Aeration (Post-conditioning)
After gas exposure, products undergo controlled aeration to reduce EO and by-products (e.g. ethylene chlorohydrin) to acceptable levels in accordance with ISO 10993-7. Depending on materials and design, this phase may take several days.
Advantages of Ethylene Oxide Sterilization
- Material-friendly: Low processing temperatures (typically 30–60 °C) protect heat-sensitive materials
- High penetration: Effective for complex geometries, long lumens and packaged products
- Broad material compatibility: Suitable for plastics, coated products, electronics and sensor-based devices
These advantages make EO sterilization a preferred option for many high-risk and technologically advanced medical devices.
Challenges and Limitations
Despite its benefits, EO sterilization presents specific challenges that manufacturers must manage carefully:
- Sterilant residues: EO and its by-products are volatile and toxic; adequate aeration is required to meet regulatory limits
- Long cycle times: Aeration can significantly extend overall processing time
- Regulatory scrutiny: Compliance with ISO standards (e.g. ISO 10993-7, ISO 11135) is mandatory, and processes must be validated
Ethylene oxid Sterilization is not the only option
Looking for alternatives such as eBeam or radiation sterilization? Talk to us about comparative feasibility and regulatory implications.
Validation of EO Sterilization Processes – ISO 11135
Validation of EO sterilization processes is performed according to ISO 11135. The Performance Qualification (PQ) phase is divided into:
- Microbiological Performance Qualification (MPQ)
- Physical Performance Qualification (PPQ)
Microbiological Performance Qualification (MPQ)
The MPQ demonstrates that the sterilization process consistently achieves a Sterility Assurance Level (SAL) of 10⁻⁶.
The most common validation approach is the overkill method (ISO 11135, Annex B), which uses biological indicators (BIs). Half-cycles and full cycles are performed to show that BIs are inactivated even under reduced exposure conditions.
Physical Performance Qualification (PPQ)
The PPQ confirms that all physical process parameters — such as EO concentration, temperature, pressure and humidity — remain within defined tolerances throughout the cycle.
ISO 11135 also describes alternative validation approaches (Annex A), which may be applicable depending on product and process characteristics.
EO Sterilization Compared to Other Methods
Compared to steam or radiation sterilization, EO offers greater flexibility and material compatibility. However, it requires:
- specialized facilities
- longer processing times
- experienced personnel
- robust residue control strategies
Selecting the appropriate sterilization method should always be based on product design, material compatibility, regulatory requirements and risk management.
Standards Update – ISO 10993-7 (EO Residues)
A key standards development relevant to EO sterilization is the update of ISO 10993-7, which defines acceptable limits for EO and ethylene chlorohydrin residues in medical devices.
- A revised draft was published in 2024
- The final version is expected in 2025
Key Update
The revised ISO 10993-7 introduces a standard reference body weight of 70 kg as the basis for residue limit calculations. This allows:
- improved transparency
- better alignment across patient populations
- more differentiated risk assessments
The exposure-category-specific limits (e.g. short-term vs. long-term use) remain unchanged, but a weight-based adjustment factor is now applied.
ISO 10993-7 continues to define:
- analytical methods for EO and ethylene chlorohydrin residues
- requirements for demonstrating compliance
For manufacturers and EO sterilization service providers, it is strongly recommended to monitor the final publication closely and update validation and risk management documentation accordingly.
Conclusion
Ethylene oxide sterilization is a highly effective and well-established sterilization method, especially for complex, sensitive and high-value medical devices. At the same time, its use requires deep technical expertise, robust validation and strict regulatory control.
For non-EU manufacturers seeking access to the European market, EO sterilization must be aligned not only with ISO standards but also with EU MDR expectations for safety, biocompatibility and risk management.
We got the expertise
Need support with Ethylene oxid sterilization strategy, validation or regulatory compliance? Learn more about our services or book a free introductory consultation.


